SCHEMBL25868526

SCHEMBL25868526

O=c1[nH]c2cc(Br)cnc2o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.49
AURKA O14965 1/20 0.49
DAPK3 O43293 1/20 0.49
JAK2 O60674 1/20 0.49
PRKD3 O94806 1/20 0.49
MAP4K4 O95819 1/20 0.49
PAK4 O96013 1/20 0.49
ABL1 P00519 1/20 0.49
NTRK1 P04629 1/20 0.49
FYN P06241 1/20 0.49
RET P07949 1/20 0.49
MET P08581 1/20 0.49
PDGFRB P09619 1/20 0.49
PIM1 P11309 1/20 0.49
FGFR1 P11362 1/20 0.49
PDGFRA P16234 1/20 0.49
FLT1 P17948 1/20 0.49
LTK P29376 1/20 0.49
GRK5 P34947 1/20 0.49
KDR P35968 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24331221 0.79 KDM4E (0.50) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL2576926 0.79 DYRK1A (0.46) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL31046993 0.79 DYRK1A (0.46) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL488612 0.70 AURKA (0.49) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL19227402 0.69 NOS1 (0.36) LMNANOS1NOS2SMN1; SMN2NOS3
SCHEMBL10326072 0.69 NOS1 (0.42) LMNANOS1NOS2KMONOS3
SCHEMBL2149064 0.69 GPR35 (0.38) LMNAALDH1A1NOS1NOS2KMO
SCHEMBL24002739 0.68 AURKA (0.46) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL3865038 0.68 DYRK1A (0.39) DYRK1AAURKADAPK3JAK2PRKD3
SCHEMBL30187131 0.68 AURKA (0.46) DYRK1AAURKADAPK3JAK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B DYRK1A 4493/4885AURKA 4402/4885DAPK3 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.